Sexual Problems During the First 2 Years of Adjuvant Treatment with Aromatase Inhibitors

Abstract

The great majority of women taking AIs have sexual dysfunction that is distressing and difficult to resolve. Most continue their AI therapy, but a large minority cease sexual activity.